File this under “If at first you don’t succeed.…”
The Trump administration plans another attempt at creating a pilot program that would alter payments for medicines purchased through a controversial federal drug discount program.
In a little-noticed posting, the U.S. Health Resources and Services Administration indicated it is pursuing a rule for a rebate model, although details were not disclosed. A previously proposed pilot program would have allowed drugmakers to offer rebates to hospitals after a medicine is dispensed, instead of providing discounts at the time of purchase.Continue to STAT+ to read the full story…